GUARANTEEGuarantee • March 2nd, 2020 • BeiGene, Ltd. • Pharmaceutical preparations
Contract Type FiledMarch 2nd, 2020 Company IndustryGuarantee (this “Guarantee”) dated as of October 31, 2019, made by and among BeiGene, Ltd., a Cayman Islands exempted company, with its registered offices c/o Mourant Governance Services (Cayman) Limited, 94 Solaris Avenue, P.O. Box 1348, Grand Cayman KY1-1108, Cayman Islands (“Parent Co.”) and Amgen Inc., a Delaware corporation, with a principal place of business at One Amgen Center Drive, Thousand Oaks, California 91320 (“Amgen”). Capitalized terms used herein but not otherwise defined have the meanings ascribed to them in the Collaboration Agreement (as hereafter defined).
BEIGENE, LTD. AMENDMENT NO. 1 TO SHARE PURCHASE AGREEMENTShare Purchase Agreement • March 2nd, 2020 • BeiGene, Ltd. • Pharmaceutical preparations • New York
Contract Type FiledMarch 2nd, 2020 Company Industry JurisdictionTHIS AMENDMENT NO. 1 (this “Amendment”) to the SHARE PURCHASE AGREEMENT, dated as of October 31, 2019 (the “Agreement”), is made and entered into as of December 6, 2019, by and among BeiGene, Ltd., an exempted company incorporated in the Cayman Islands (the “Company”), and Amgen Inc., a Delaware corporation (the “Investor”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Agreement.
CERTAIN INFORMATION (INDICATED BY “[…***…]”) AND SCHEDULES HAVE BEEN EXCLUDED FROM THIS AGREEMENT BECAUSE SUCH INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. SHARE PURCHASE AGREEMENTShare Purchase Agreement • March 2nd, 2020 • BeiGene, Ltd. • Pharmaceutical preparations • New York
Contract Type FiledMarch 2nd, 2020 Company Industry JurisdictionThis SHARE Purchase Agreement (the “Agreement”) is made and entered into as of October 31, 2019 (the “Signing Date”), by and between BeiGene, Ltd., an exempted company incorporated in the Cayman Islands (the “Company”), and Amgen Inc., a Delaware corporation (the “Investor”).
CERTAIN INFORMATION (INDICATED BY “[…***…]”) AND SCHEDULES HAVE BEEN EXCLUDED FROM THIS AGREEMENT BECAUSE SUCH INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. AMGEN INC. BEIGENE SWITZERLAND GMBH and...Collaboration Agreement • March 2nd, 2020 • BeiGene, Ltd. • Pharmaceutical preparations • New York
Contract Type FiledMarch 2nd, 2020 Company Industry Jurisdiction
ASSIGNMENT AND ASSUMPTION AGREEMENT December 29, 2017Assignment and Assumption Agreement • March 2nd, 2020 • BeiGene, Ltd. • Pharmaceutical preparations
Contract Type FiledMarch 2nd, 2020 Company Industryentered into by and between BeiGene, Ltd., a corporation organized and existing under the laws of Cayman Islands (the “Assignor”), and BeiGene Switzerland GmbH, a company organized and existing under the laws of Switzerland (the “Assignee”).